Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 9
2005 17
2006 14
2007 15
2008 28
2009 36
2010 47
2011 62
2012 52
2013 98
2014 91
2015 90
2016 105
2017 90
2018 83
2019 95
2020 94
2021 106
2022 83
2023 98
2024 89
2025 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,286 results

Results by year

Filters applied: . Clear all
Page 1
Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy-Induced Necrosis.
Ghosh S, Yang R, Duraki D, Zhu J, Kim JE, Jabeen M, Mao C, Dai X, Livezey MR, Boudreau MW, Park BH, Nelson ER, Hergenrother PJ, Shapiro DJ. Ghosh S, et al. Among authors: kim je. Cancer Res. 2023 Sep 15;83(18):3115-3130. doi: 10.1158/0008-5472.CAN-23-0157. Cancer Res. 2023. PMID: 37522838 Free PMC article.
A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma.
Dong W, Fekete A, Chen X, Liu H, Beilhartz GL, Chen X, Bahrampour S, Xiong Y, Yang Q, Zhao H, Kong T, Morioka MS, Jung G, Kim JE, Schramek D, Dirks PB, Song Y, Kim TH, He Y, Wanggou S, Li X, Melnyk RA, Wang LY, Huang X. Dong W, et al. Among authors: kim je. Nat Cancer. 2023 Oct;4(10):1418-1436. doi: 10.1038/s43018-023-00626-8. Epub 2023 Sep 11. Nat Cancer. 2023. PMID: 37697045
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Yun HJ; KCSG TRIUMPH Investigators. Keam B, et al. Among authors: kim je. J Clin Oncol. 2024 Feb 10;42(5):507-517. doi: 10.1200/JCO.22.02786. Epub 2023 Sep 12. J Clin Oncol. 2024. PMID: 37699162 Clinical Trial.
Artificial sensory system based on memristive devices.
Kwon JY, Kim JE, Kim JS, Chun SY, Soh K, Yoon JH. Kwon JY, et al. Among authors: kim je. Exploration (Beijing). 2023 Nov 20;4(1):20220162. doi: 10.1002/EXP.20220162. eCollection 2024 Feb. Exploration (Beijing). 2023. PMID: 38854486 Free PMC article. Review.
Controlled S-nitrosation.
Tannenbaum SR, Kim JE. Tannenbaum SR, et al. Among authors: kim je. Nat Chem Biol. 2005 Aug;1(3):126-7. doi: 10.1038/nchembio0805-126. Nat Chem Biol. 2005. PMID: 16408013 No abstract available.
1,286 results